Disc Medicine (NASDAQ: IRON) — Perfil da empresa, notícias e dados financeiros
Disc Medicine is a biotechnology company developing treatments for serious hematologic diseases with innovative therapies.
Disc Medicine
Disc Medicine (NASDAQ:IRON) is a biotechnology entity dedicated to discovering and developing treatments for serious hematologic diseases. Focusing on the intricate balance of iron in the body and its related disorders, Disc Medicine aims to tackle conditions with significant unmet medical needs. Among their projects are innovative therapies aimed at treating anemias and other iron metabolism disorders, striving to bring new hope and solutions to patients worldwide. Their objective is to advance the understanding of hematologic diseases at the molecular level, leading to groundbreaking treatments that improve patient outcomes and quality of life.
Resumo
Operações
Produtos e/ou serviços de Disc Medicine
- Development of therapies targeting the hepcidin pathway for the treatment of iron disorders.
- Innovative treatments for hematologic diseases focusing on improving patients' quality of life.
- Research into erythropoiesis signaling pathways to address anemias.
- Collaboration with pharmaceutical companies to accelerate drug development in hematology.
- Provision of comprehensive patient support programs for those undergoing treatment for blood disorders.
- Engagement in community education and awareness initiatives around hematological health issues.
equipe executiva do Disc Medicine
- Donald William NicholsonExecutive Chairman
- John D. QuiselCEO, President & Director
- Jean M. FranchiChief Financial Officer
- Jonathan YuChief Opearating Officer
- William Jacob SavageChief Medical Officer
- Pamela StephensonChief Commercial Officer
- Brian MacDonald ChBFounder & Chair of Scientific Advisory Board
- Rahul Rajan KaushikChief Technical Officer
- Rahul KharaChief Legal Officer & Secretary
- Lisa Amaya PriceChief Human Resources Officer
Últimas notícias sobre a Disc Medicine
Principais indicadores financeiros
Resultados divulgados pela Disc Medicine, em USD.
- Cap. de mercado
- 3,5 bi
- Receita (TTM)
- 0
- P/L
- —
- LPA (diluído, TTM)
- -6.9
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 0 | -236 mi | -212,2 mi | |
| 0 | -129,7 mi | -109,4 mi | |
| 0 | -91,1 mi | -76,4 mi | |
| 0 | -47,5 mi | -46,1 mi |